Background: Research into asthma is proceeding at an unprecedented rate and yet we live with a disease that escalates in prevalence and severity, despite a greater understanding of its pathophysiology and the necessary therapy. The total prevalence of asthma is estimated to lie at 7.2% of the world's population (6% in adults, 10% in children). Data from Australia, Canada and Spain report that acute asthma accounted for 1 to 12% of all adult emergency department visits. The prevalence of asthma in South Africa lies at 5% for adults and 10% for children. Asthma is reported as taking up 1 to 2% of the total health budget in direct costs, with equally large indirect costs being incurred for time lost from work and reduced productivity. It has also been reported that approximately one-third of the direct care costs of asthma are attributable to emergency department visits and hospitalisations. In some cases, exposure may be unavoidable (for example exposures to cold air, exercise or the asthma-inducing effects of pregnancy). Many studies have been done in other countries on specific triggers, especially allergens and viral respiratory infections. However, circumstances differ in the public sector in South Africa and other factors such as compliance and under-treatment, which may be applicable, should be studied in contention.
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Background
Research into asthma is proceeding at unprecedented rates and yet we live with a disease that is escalating in prevalence and severity, despite a greater understanding of its pathophysiology and the necessary therapy. [1] [2] [3] [4] The total prevalence of asthma is estimated to lie at 7.2% of the world's population (6% in adults, 10% in children). 5 Data from Australia, Canada and Spain report that acute asthma accounts for 1 to 12% of all adult Emergency Department (ED) visits. 6 The prevalence of asthma in South Africa lies at 3.8% for adults 7 (3% for males and 4.4% for females) 8 and 13.3% for adolescents. 9 Green et al report that asthma takes up 1 to 2% of the total health budget in direct costs, with equally large indirect costs being incurred for time lost from work and reduced productivity. 10 Osur states that approximately one-third of the direct care costs of asthma are attributable to ED visits and hospitalisations. 2 The reasons for rising rates of morbidity and mortality connected with asthma are unclear. Case-control studies using retrospectively collected data have suggested that excess use of short-acting ß-agonists and under-use of inhaled corticosteroids may be associated with this phenomenon, although more recent data suggest that patterns of ß 2 -agonist use may be a marker of more severe asthma rather than a causal factor. 1 The beneficial effects of inhaled steroids when used as maintenance therapy in chronic asthma are well known. When used regularly, inhaled steroids decrease the number of asthma exacerbations caused by most triggers, including exercise. 11 This fact has also been recognised in a Cape Town study, in which it was concluded that practitioners should increase the use of current asthma guidelines, as under-treatment is a huge problem. 12 Patients at any level of severity -from mild intermittent to severe persistent -can have exacerbations. Each patient with asthma responds to a unique set of triggers. In some cases, exposure may be unavoidable (for example, exposures to cold air, exercise or the asthma-inducing effects of pregnancy). 13 Many triggers can provoke asthma exacerbations. According to the literature the following are possibilities: (1) Many studies have been done in other countries on specific triggers, especially allergens and viral respiratory infections. However, circumstances differ in the public sector in South Africa, and other factors such as compliance and under-treatment, which may be applicable in this context, should be studied in contention.
Methods
The setting for this study was the emergency unit, the primary health clinic and the asthma clinics at the secondary family medicine and internal medicine outpatient departments at Kalafong Hospital, a secondary regional and teaching hospital affiliated to the University of Pretoria. The study population consisted of adult asthma patients between 18 and 65 years of age, who were representative of the communities served by Kalafong Hospital.
The study design used was a matched case-control study -matched on age and gender. Each of the cases was matched with two controls. Known asthma patients were considered cases if they had developed an acute asthma exacerbation, defined as shortness of breath, chest tightness, wheezing and a peak expiratory flow rate (PEFR) that was at least 15 to 25% less than normal, requiring an ED visit, between December 2003 and May 2005. Known asthma patients were considered controls if they had had no exacerbations requiring emergency visits during the preceding month. Controls were recruited from the primary health clinic, secondary family medicine clinic and the internal medicine outpatients department.
Inclusion criteria for study participants
Inclusion criteria for the study participants consisted of the following:
• Diagnosis of asthma according to the National Guidelines of Management of Asthma in Adults at the Primary Level: Department of Health Directorate: Chronic Diseases, Disabilities and Geriatrics. 22 • Duration of asthma of more than one year.
• Attendance of an asthma clinic at the family medicine or internal medicine departments of Kalafong Hospital for six months or longer. The investigator used a structured questionnaire as a basis for interviewing the participants, after obtaining informed consent from the participants to interview them. Information obtained from the questionnaire about exposure to possible triggers included age, gender, compliance, literacy, allergic rhinitis, infections, exercise, passive smoking, in-house coal fires, adverse drugs, stress/anxiety, exposure to household pets, premenstrual/menstrual phases, pregnancy, work-related exposures and under-treatment. Exposure to triggers was noted for the previous four weeks in both cases and controls.
Exclusion criteria

Definitions of possible trigger/risk factors
The definitions of the possible trigger/risk factors are set out below.
Non-compliance
Non-compliance was identified as a trigger/risk factor when participants missed one or more doctor's appointment in the past six months, or missed one or more script appointment in the past six months or did not take medication as prescribed. The patients were required to describe exactly how they used their medication, and this was compared to the prescriptions in their files. The doctor and script appointments were available from each patient's file.
Literacy level
The following four sub-groups were included: 1. No schooling 2. Some primary schooling 3. Some high school training 4. Matriculation A low literacy level was seen as a trigger/risk factor.
Severity of the chronic phase of asthma
The following four sub-groups were investigated in accordance with the Guidelines for the Management of Chronic Asthma in Adults -2000 Update. 
Under-treatment
The prescribed medication of the patient was evaluated against the severity of the chronic phase of the patient's asthma as specified in the guidelines for the management of chronic asthma in adults. 23 Under-treatment was defined as the omission of corticosteroid inhalers to patients who qualified for treatment with them or the prescription of inappropriate dosages of inhaled corticosteroids. All insufficient prescriptions were seen as a trigger/ risk factor.
Exercise/sport
Participation in any formal or informal sport activities was seen as a possible trigger/risk factor for an asthma exacerbation. This included walking distances of at least 1 km.
Viral infections
A viral infection was seen as a trigger/risk factor when at least three of the following five components on the questionnaire were marked positive: 1. Sore throat 2. Fever 3. Runny/blocked nose 4. Muscle aches 5. Exposure to other people with a cold
Household pets
This trigger/risk factor was restricted to cats or caged birds in the house or in the direct work place.
Passive smoking
Passive tobacco smoking indoors at home, at the work place or at any other institution was seen as a trigger/risk factor.
Strong emotions
The following types of strong emotion were considered as trigger/ risk factors:
Anger
Anger was seen as a trigger/risk factor when a participant had any loss of temper.
Excitement
Excitement was seen as a trigger/risk factor when a participant was extremely excited or happy about something, such as gifts, sports, finances or relationships.
Anxiety
Anxiety was seen as a trigger/risk factor when a participant was anxious for reasons related to crime or the death of a relative, for example, or when the participant was having an anxiety attack.
Coal stoves
Exposure of participants to in-house wood burning or to coal stoves was seen as a trigger/risk factor.
Weather
Weather was seen as a trigger/risk factor for all participants experiencing rainy weather conditions during their exposure assessment period.
Medication
The following types of medication were considered as trigger/risk factors:
Nonsteroidal anti-inflammatory drugs (NSAIDs)
Any orally ingested, rectally inserted or injected NSAID received by participants was seen as a trigger/risk factor for acute asthma exacerbations.
β-blockers
Any β-blocker-containing medication was seen as a trigger/risk factor. This included eye drops, intravenous preparations and tablets.
Allergic rhinitis
Allergic rhinitis was seen as a trigger/risk factor when symptoms were present for more than one hour per day over two weeks and when at least two of the following four components on the questionnaire were marked positive: 1. Blocked nose 2. Sneezing 3. Runny nose 4. Seasonal symptoms
Work-related exposures
Work-related exposures were seen as a trigger/risk factor when participants were exposed to, for example, spray-painting, diisocyanate or when they were employed in the pharmaceutical, plastics or platinum industries.
Pregnancy, menopause, and premenstrual/menstrual phases
All female participants were evaluated regarding pregnancy, menopause or their menstrual cycles. Pregnancy was diagnosed with a positive β-human chorionic gonado trophins (β-HCG) blood test and menopause was established from a history of normal cessation of menstruation. Premenstrual/menstrual phases were seen as a possible trigger/risk factor for cases in their premenstrual or menstrual phase during an exacerbation and for controls with no amenorrhoea in the previous four weeks.
Prescribed medication
Prescribed medication was recorded from the patients' files. This included β-agonist-, ipratropium bromide, beclomethasone and budesonide inhalers, oral theophylline, long-acting β 2 -agonists and daily oral steroids.
Statistical package used
Univariate statistical analysis was done to assess characteristics and risk factors of participants. The Intercooled Stata 8.1 (Intercooled for 
Ethical considerations
The Ethics Committee of the Faculty of Human Health Sciences of the University of Pretoria authorised the study, which was conducted in accordance with the ethical principles of the Declaration of Helsinki and Geneva Declaration of the World Medical Association.
Results
A total of 150 patients were recruited: 50 cases with acute asthma exacerbations, from the emergency unit, and 100 controls with stable asthma, from the outpatient departments. Results (see Table I ) revealed that cases were more likely than controls not to comply with treatment (OR = 2.18; 95% CI 1.09 to 4.38; p = 0.03). According to responses to the questionnaire, respiratory viral infections were present in 32% of cases and in 23% of controls. The literacy level (matriculation) was higher in cases than controls -34% versus 16%.
Females were more likely to be included in the study, as 84% of participants were females and only 16% were males. Under-treatment was detected in less than 20% of cases and controls. Rainy weather was present in 82% of cases and also in 90% of controls. More female controls (46%) than cases (38%) were in their menopause. Although more cases than controls were exposed to passive smoke (36% versus 26%) and to non-steroid anti-inflammatory drugs (40% versus 34%), these results were not statistically significant.
The parameters used to determine non-compliance are shown in Table II . Only one of the three parameters needed to be fulfilled in order to mark a participant as not complying. "Missing follow-up appointments in the last six months" was statistically significant, with an OR of 2.39 (95% CI 1.08 to 5.27) and p = 0.03. Analysis of the case-control data was also done with conditional logistic regression to assess clinically relevant and statistically significant variables identified in the univariate analysis. The final model consisted of the dependent variable (case/control) and non-compliance. The odds ratio was found to be 2.82 with CI 1.31 to 6.10; p = 0.008.
In Table III all the medication prescribed for the cases and controls is shown. There was no difference of note between the cases and controls. Daily oral steroids were prescribed for six cases − only three of these cases had severe persistent asthma in the dataset − and for eight controls, with only one severe persistent participant. One participant received two β-agonist inhalers and another participant did not receive a budesonide inhaler from the pharmacy although it was prescribed. In total, 88% of cases and 93% of controls were on inhaled corticosteroids.
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Discussion
This was a matched case-control study, investigating the potential triggers or risk factors causing exacerbations in known adult asthma patients in a hospital setting. A significant association was shown between non-compliance and asthma exacerbations. Compliance was determined by (1) evaluating the patients' records to decide whether they kept follow-up appointments; (2) evaluating the prescription chart for script follow-ups; and (3) interviewing each patient to assess whether they used medication as prescribed. According to the literature, poor adherence to therapy is a common phenomenon.
17
Social class might have been a potential confounding factor here, but the controls and cases were selected from the same environment and communities. This effectively matched for social class and indicated that the results are unlikely to be the result of misclassifications. Many of the patients who did not keep follow-up appointments complained about money and transport problems.
The literacy level (matriculation) was higher in cases than in controls. One can therefore speculate that education would not decrease the number of asthma exacerbations. Under-usage of inhaled corticosteroids was one of the major elements that surfaced in response to interview questions on the use of prescribed medication. This has also been found in other studies. 1, 10 A study conducted by Green et al, 3 for example, found that patients did not know the difference between controller and reliever treatment.
According to some studies, 40 to 50% of asthma exacerbations are caused by viral upper respiratory infections. 2, 18 A British study undertaken by Green et al10 in a large district hospital detected viruses in 26% of acute asthma and 18% of stable asthma control patients with polymerase chain reaction (PCR) assays. This study found that viral infection was noticeably less common in adults admitted to hospital with acute asthma than in children or adults having asthma exacerbations in the community. 10 In our study the odds ratio for viral infections in the exposure assessment was only 1.5 (p = 0.26). This could be ascribed to the high occurrence (23%) of viral infections in the controls. Green et al explained this phenomenon, which also occurred in their study (controls of 18%), by stating that patients with asthma are more susceptible to viral infections than patients without asthma, but that such an infection may not necessarily induce a deterioration in asthma to the point where hospital admission is required. 10 Tan et al. confirm this in their study in which viruses were recovered from asymptomatic adolescents with asthma. 18 This finding corresponds with the findings of our study.
The definitive diagnosis of respiratory viral infections is complicated by the lack of commercial availability of a rapid and cost-effective laboratory test to confirm the presence of viral respiratory infections. 18 In this study questionnaires, and not cultures of nasopharyngeal swabs and serology, were used to evaluate the presence of respiratory viral infections. According to Osur, polymerase chain reaction (PCR) is only available in the research setting. Therefore, in the evaluation of typical viral infections, clinical signs and symptoms are the clinician's only tool for establishing the diagnosis of viral respiratory infections. 2 Although the approach of self-administered questionnaires or interviews was cost-effective, the quality of this data was variable, in part because many exposures were inherently difficult to specify and quantify, and in part because of the difficulty the participants experienced in recalling events that had occurred in the past. Some of these inaccuracies could be reduced with careful questionnaire design but even with the best design considerable exposure misclassification might be expected.
In accordance with a Canadian study, 24 our controls were chronic asthmatics with no exacerbations during the preceding four weeks, selected from the asthma clinics at Kalafong Hospital. Controls were selected longitudinally throughout the course of the study (density sampling). This did not involve a random sample of the person-time in the study base since controls were only sampled for the 'instantaneous' time periods in which cases occurred. Controls could become cases later during the study, but cases could not become controls.
Limitations
This study cannot be generalised beyond the study population, as it involved patients within the public sector and at a single centre.
Definitive diagnosis of respiratory viral infections was not done with the use of laboratory tests such as serology, culture confirmation or PCR. Questionnaires on clinical symptomatology were used instead.
Recommendations
Self-management should be an important goal for asthma patients. The key features of a self-management programme would be a written action plan, the monitoring of asthma symptoms and the scheduling of regular reviews. 17 Doctors could help patients follow their selfmanagement programme.
A pharmacist care programme in which the pharmacist monitors symptoms, provides medication counselling, helps resolve drug-related problems and facilitates communication with the patients' doctors may be able to enhance patients' adherence to therapy and outcomes. 25 Patients with asthma should be motivated and receive education on the proper and regular use of inhalers. Doctors should also explain to them the appropriate dosing according to the severity level of their asthma in order to promote compliance.
Conclusion
To conclude, non-compliance was a strong predictor of exacerbations in adult asthma patients at Kalafong Hospital, which forms part of a third world community. Viral infections were, however, still common in cases without inducing deterioration in asthma to the point where hospital admission was required.
